Given the significant correlation of GAD1 mutation and methylation with prostate cancer clinicopathology, this study also explored the interaction of GAD1 expression, copy number and methylation with the immune microenvironment in prostate cancer. This evidence concerns the gene GAD1 and prostate carcinoma.